Meixin Health’s Meishu Technology was selected for WAIC 2026’s typical practices for data-asset empowerment of intelligent agents

robot
Abstract generation in progress
On July 19, the WAIC 2026 (2026 World Artificial Intelligence Conference) “Data Elements × Industry Agents” forum opened in Shanghai. At the event, 2026 Typical Practices for Empowering Agents with Data Elements (2026) were unveiled. Leveraging the company’s advantages in pharmaceutical insurance data and applying them to the vertical scenario of innovative drug patient services, “KnowDrug.ai ZhiYao” by MeiShu Technology, a subsidiary of Meixin Health, was successfully selected. KnowDrug.ai builds an intelligent service system covering key steps such as disease understanding, patient management, and medication support. It connects pharmaceutical companies, medical service providers, and patients, enabling a two-way improvement in both the release of commercial value for innovative drugs and health benefits for patients.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned